Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FILM: Ocrelizumab + MTX in MTX-naive RA
NCT00485589Phase 3Terminated
- Sponsor
- Genentech
- Start
- Jun 2007
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of ocrelizumab in rheumatoid arthritis (RA), sponsored by Genentech. Started Jun 2007; status: terminated.
02
Drugs
ocrelizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00485589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485589.